A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel

Research output: Contribution to journalJournal articleResearchpeer-review

  • Pierre Maison-Blanche
  • Jan B Vermorken
  • Tuncay Goksel
  • Jean-Pascal Machiels
  • Sanjiv Agarwala
  • Sylvie Rottey
  • Gedske Daugaard
  • Constantin Volovat
  • Max Scheulen
  • Lisa Sengeløv
  • Dana Grecea
  • Alexandru Eniu
  • Elke Jäger
  • Eyal Meiri
  • Stefano Cascinu
  • Dirk Strumberg
  • Gokhan Demir
  • Michael Clemens
  • Graziella Pinotti
  • Mario Nardi
  • And 3 others
  • Troy Guthrie
  • Emmanuelle Boelle
  • Emmanuelle Magherini
Original languageEnglish
JournalJournal of Cardiovascular Pharmacology
Volume61
Issue number6
Pages (from-to)495-504
Number of pages10
ISSN0160-2446
DOIs
Publication statusPublished - 2013

ID: 118828606